April 21, 2020
Schwendinger M et al. J Infect Dis 2020;jiaa121.
A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus
You might also be interested by
Infographics
Next-Generation Flow Cytometry Analysis with CellEngine™
January 31, 2023
Immune Monitoring
More infoCellTalk Blog
Discover Metadata-Driven Cytometry Analysis With CellEngine™
January 31, 2023
Immune Monitoring
More infoCellTalk Blog
Easy, Customized Autogating With CellEngine™
December 14, 2022
Immune Monitoring
More info